ProQR Therapeutics N.V. (PRQR) Financials

PRQR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 152.4 million 61.7 million
March 31, 2026 130.8 million 81.1 million
Dec. 31, 2025 155.5 million 87.4 million
Sept. 30, 2025 171.5 million 92.8 million

PRQR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -14.5 million ?
March 31, 2026 -13.0 million 1.6 million
Dec. 31, 2025 -16.3 million 1.4 million
Sept. 30, 2025 -14.6 million 1.3 million

PRQR Net Income

No data available :(

PRQR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 133.6 million - 9.9 million
March 31, 2026 107.1 million - 12.0 million
Dec. 31, 2025 127.4 million - 13.2 million
Sept. 30, 2025 147.4 million - 13.8 million

PRQR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 125.5 million
March 31, 2026 120.7 million
Dec. 31, 2025 120.9 million
Sept. 30, 2025 129.2 million

PRQR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 336429 14.7 million 4.9 million -
March 31, 2026 187937 13.8 million 4.4 million -
Dec. 31, 2025 617504 11.6 million 4.6 million -
Sept. 30, 2025 198326 13.0 million 3.7 million -

PRQR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 10.2 million 820242
March 31, 2026 2.4 million 808374
Dec. 31, 2025 5.5 million 789644
Sept. 30, 2025 3.4 million -

PRQR

Price: $1.31

52 week price:
1.31
3.10

Earnings Per Share: -0.46 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Netherlands

Volume: 1.0 million

Ebitda: -11.0 million

Market Capitalization: 172.0 million

Links: